necessity prior to the end of such period of time. Clause 4. In the case where there appears later a change of any material information provided in the application filed with the Office, the securities
necessity prior to the end of such period of time. Clause 4. In the case where there appears later a change of any material information provided in the application filed with the Office, the securities
later a change of any material information provided in the application filed with the Office, the securities company shall notify the Office within fourteen days from the date of the change of such
223,900 80,751 22,292 20,512 28,222 Change (25,507) (8,341) 783 2,010 (4,514) % Change (10.23%) (9.36%) 3.64% 10.86% (13.79%) In overall, the Company and its subsidiaries had a net profit in Q3/ 2019 of 28
Revenue by Product Line for the three months period ended March 31 (YoY) Product Line/ Business Group Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 31 March 2018
Bt559.7million in the third quarter of 2018. A summary of the Company’s operating performance in the third quarter of 2019 and 2018 is shown in the following table: 3Q19 2Q19 1Q19 % Change 3Q18 % Change [Amount in
Topic Balance by Quarter Change Q1–21 Q4–20 Q1–20 Q1–21 VS Q4–20 Q1–21 VS Q1–20 (Million Baht: MB) (MB) % (MB) % Total revenue 1,824.2 2,070.7 1,231.6 (246.5) (11.9) 592.6 48.1 Total operating expenses
Topic Balance by Quarter Change Q1–21 Q4–20 Q1–20 Q1–21 VS Q4–20 Q1–21 VS Q1–20 (Million Baht: MB) (MB) % (MB) % Total revenue 1,824.2 2,070.7 1,231.6 (246.5) (11.9) 592.6 48.1 Total operating expenses
December 2018 thanks to strong support from our shareholders. In May 2018, BGRIM was also selected to be in the ESG100 list (Environmental, Social and Governance) by Thaipat Institute to reflect the company
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change